Edition:
United Kingdom

Akorn Inc (AKRX.OQ)

AKRX.OQ on NASDAQ Stock Exchange Global Select Market

13.90USD
23 May 2018
Change (% chg)

$0.17 (+1.24%)
Prev Close
$13.73
Open
$13.69
Day's High
$14.34
Day's Low
$13.69
Volume
346,234
Avg. Vol
633,060
52-wk High
$33.95
52-wk Low
$10.76

Latest Key Developments (Source: Significant Developments)

Akorn Issues Statement In Response To Fresenius Seeking To Terminate Merger
Sunday, 22 Apr 2018 

April 22 (Reuters) - Akorn Inc ::AKORN INC ISSUES STATEMENT IN RESPONSE TO FRESENIUS KABI’S ANNOUNCEMENT THAT IT IS SEEKING TO TERMINATE THE DEFINITIVE MERGER AGREEMENT.AKORN SAYS PREVIOUSLY DISCLOSED ONGOING INVESTIGATION HAS NOT FOUND ANY FACTS THAT WOULD RESULT IN ADVERSE EFFECT ON CO'S BUSINESS.AKORN SAYS SINCE INVESTIGATION DID NOT FIND ANY FACTS RESULTING IN ADVERSE EFFECT ON CO'S BUSINESS, IT IS "NO BASIS TO TERMINATE THE TRANSACTION".AKORN SAYS INTEND TO "VIGOROUSLY" ENFORCE CO'S RIGHTS, AND FRESENIUS’ OBLIGATIONS, UNDER BINDING MERGER AGREEMENT.  Full Article

Fresenius SE & Co. KGaA Fresenius Terminates Merger Agreement With Akorn
Sunday, 22 Apr 2018 

April 22 (Reuters) - Fresenius SE & Co KGaA ::DGAP-ADHOC: FRESENIUS SE & CO. KGAA: FRESENIUS TERMINATES MERGER AGREEMENT WITH AKORN.  Full Article

SEC Says Akorn Inc Agrees To Settle To Reporting, Accounting Control Violations
Monday, 26 Mar 2018 

March 26 (Reuters) - Akorn Inc ::SEC SAYS AKORN INC AND ITS FORMER CFO AND CONTROLLER AGREE TO SETTLE TO REPORTING AND ACCOUNTING CONTROL VIOLATIONS.SEC - AKORN INC, FORMER CFO & CONTROLLER AGREED TO SETTLE THE CHARGES WITHOUT ADMITTING OR DENYING THE COMMISSION'S ALLEGATIONS.  Full Article

Fresenius confirms discussions concerning potential acquisition of Akorn
Friday, 7 Apr 2017 

Fresenius Se : Co and Akorn Inc don't intend to make any additional comments regarding these negotiations unless and until it is appropriate to do so . Currently in discussions with Akorn concerning a potential acquisition of Akorn . Confirms that Fresenius Kabi is currently in discussions with Akorn Inc concerning a potential acquisition of Akorn .No assurance any transaction will result from these discussions or as to terms of any such transaction.  Full Article

Fresenius said to weigh a bid for U.S. generics maker Akorn - Bloomberg
Friday, 7 Apr 2017 

:Fresenius said to weigh a bid for U.S. generics maker Akorn - Bloomberg.  Full Article

Akorn reported Q2 EPS $0.50
Thursday, 4 Aug 2016 

Akorn Inc : Q2 GAAP earnings per share $0.50 . Q2 adjusted NON-GAAP earnings per share $0.58 including items . Akorn provides second quarter 2016 results . Q2 revenue $281 million versus i/b/e/s view $273 million . Sees FY 2016 revenue $1.06 billion to $1.08 billion . Q2 earnings per share view $0.55 -- Thomson Reuters I/B/E/S . Expects that full year GAAP earnings per share will be at upper end of previously communicated ranges of $1.56 - $1.66 . Expects that full year NON-GAAP earnings per share will be at upper end of previously communicated ranges of $2.10 - $2.20 . FY2016 earnings per share view $2.15, revenue view $1.08 billion -- Thomson Reuters I/B/E/S .Board of Directors authorizes $200 million stock repurchase program.  Full Article

Photo

Fresenius CEO defends canceled Akorn deal

FRANKFURT/BERLIN Fresenius SE's chief executive has defended the company's decision to pull out of a planned $4.8 billion takeover of Akorn , saying it was the only option after uncovering data integrity breaches at the U.S drugmaker.